about
Potent inhibition of thyroid cancer cells by the MEK inhibitor PD0325901 and its potentiation by suppression of the PI3K and NF-kappaB pathwaysEvidence for transcriptional and posttranscriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors.PPARγ Promotes Growth and Invasion of Thyroid Cancer CellsTreatment outcome of patients with anaplastic thyroid cancer: a single center experienceRecent advances in molecular biology of thyroid cancer and their clinical implications.Fungating thyroid cancer: a complex clinical scenario.Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy.Histological study of papillary thyroid carcinoma treated with percutaneous ethanol injection therapy.Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis.Combined Effects of Baicalein and Docetaxel on Apoptosis in 8505c Anaplastic Thyroid Cancer Cells via Downregulation of the ERK and Akt/mTOR Pathways.
P2860
Q33801421-7A5DA1F7-CCD4-4ED0-ADD1-F8EE8534990BQ35102863-353EAA50-CA69-4D4B-A6C4-D861C573AA75Q35608757-DB0B0896-A66A-4EDA-A0B4-B7C554351333Q35767404-3897DD8F-E1E6-479C-887A-68BEFE2F1AE9Q37041330-ACDF5067-2A53-4BAE-B009-65AF55952E5EQ37972261-E9211A8D-D848-4F81-ABAE-6699C545D9CBQ39315516-15321823-342E-4BBE-A5B6-1EA758B3867DQ44052075-FA8F2507-4F08-44AB-9530-C8EC5E4E5DE9Q44948377-CDCBE958-9F16-46D7-B6A2-D32BCE7A9D92Q53076797-5F4CE000-016A-4A52-B903-7C6EEB29BE6D
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Management of undifferentiated thyroid cancer.
@ast
Management of undifferentiated thyroid cancer.
@en
Management of undifferentiated thyroid cancer.
@nl
type
label
Management of undifferentiated thyroid cancer.
@ast
Management of undifferentiated thyroid cancer.
@en
Management of undifferentiated thyroid cancer.
@nl
prefLabel
Management of undifferentiated thyroid cancer.
@ast
Management of undifferentiated thyroid cancer.
@en
Management of undifferentiated thyroid cancer.
@nl
P356
P1476
Management of undifferentiated thyroid cancer.
@en
P2093
P304
P356
10.1053/BEEM.2000.0106
P577
2000-12-01T00:00:00Z